Drug - Hemangeol™ (propranolol HCl oral solution) [Pierre Fabre Pharmaceuticals, Inc.]
Therapeutic area - Beta-adrenergic blocking agents
FDA approved indications
Hemangeol oral solution is a beta-adrenergic blocker indicated for the treatment of proliferating infantile hemangioma requiring systemic therapy.
- Patient has a diagnosis of proliferating infantile hemangioma AND
- Patient has tried and failed the generic propranolol HCL oral solution
Approvals will not be granted for any other diagnosis.
MHCP Provider Call Center 651-431-2700 or 800-366-5411